1 — 3
TACHYON

Revolutionizing Medical Diagnostics and Treatment

Originally from edition.cnn.com

Tachyon by HQ Technologies is a revolutionary in-vitro point-of-care tool that utilizes advanced long-read sequencing and sophisticated bioinformatics to transform medical diagnostics and treatment. Developed by the British-German MedTech company HQ Science Ltd., and endorsed by global health and defense leaders, Tachyon delivers rapid, precise, and cost-effective genetic analysis directly from clinical samples.
This versatile device excels in various medical applications, from routine clinical care to emergency response. Its capability to quickly and accurately analyze genetic material makes it an invaluable asset in both personalized medicine and public health. By integrating cutting-edge technology with real-time data analysis, Tachyon is set to redefine how personalized diagnostics and treatments are conducted, paving the way for significant advancements in healthcare.

Key Technological Features

Speed and Efficiency:

Tachyon drastically reduces the time needed for gene sequencing and data analysis. It delivers results within hours, enabling healthcare providers to make rapid, informed decisions crucial for effective medical interventions.

Versatility:

This technology is adaptable for numerous medical applications, including oncology, genetics, and personalized medicine. Its universal application makes it invaluable in healthcare, research, and biotechnology sectors.

Artificial Intelligence:

Tachyon uses advanced AI algorithms for fast and precise data analysis. This enhances the efficiency of diagnostics, providing detailed insights that inform personalized treatment plans tailored to individual patients.

High Sample Throughput:

Designed to process multiple samples simultaneously, Tachyon increases the capacity for high-throughput sequencing. This significantly cuts down overall processing time, making it ideal for settings requiring rapid turnaround.

Cost-Efficiency:

By streamlining sequencing processes and cutting analysis times, Tachyon lowers the costs associated with genetic diagnostics, making advanced medical technology more accessible and affordable.

Use Cases

Radiation Preparedness - Radiological Emergency Response:

Tachyon Guardian, a specialized version of the device, is pivotal in radiological emergency preparedness. In collaboration with the UK Health Security Agency (UKHSA), Tachyon is going to integrated into the UK's emergency protocols. It can rapidly assess radiation exposure in blood samples, reducing response times from days to hours. This capability greatly enhances the efficiency of emergency triage and national response strategies.

Oncoradio DX - Personalized Radiation Oncology:

In radiation oncology, Tachyon provides highly personalized diagnostics by tailoring radiation therapy to each patient’s genetic profile. It optimizes dosing to maximize treatment efficacy and minimize side effects. Tachyon’s rapid, real-time analysis of molecular data allows for immediate adjustments to treatment plans, significantly improving clinical outcomes and ensuring precise, effective radiation therapy.

Antimicrobial Resistance (AMR) - Combatting AMR:

Tachyon is adept at addressing antimicrobial resistance (AMR) by rapidly sequencing pathogen genomes and detecting resistance genes and mutations. This detailed genetic mapping offers critical insights into the pathogen’s capabilities, guiding immediate clinical responses. Tachyon’s comprehensive analysis extends to plasmids and genetic elements that spread resistance, enabling personalized antimicrobial therapy and supporting efforts to monitor and control resistant pathogens.

Pathogen Detection - Advanced Pathogen Identification:

Tachyon revolutionizes pathogen detection by decoding entire genomes of bacteria, viruses, or fungi directly from clinical samples. This allows for the swift and accurate identification of pathogens, including closely related strains. The device provides detailed genetic insights into pathogen behavior, such as virulence factors and resistance genes, which are crucial for developing targeted and effective treatment strategies.

Sepsis Management - Transformative Sepsis Care:

In managing sepsis, a critical condition caused by the body’s response to infection, Tachyon's rapid sequencing capabilities are vital. It quickly identifies a wide range of pathogens from a patient’s blood, facilitating the timely initiation of appropriate treatment and improving survival rates. Beyond pathogen identification, Tachyon provides insights into resistance genes, allowing for precise tailoring of antimicrobial therapy. Its real-time data processing produces actionable reports, enabling quick and informed clinical decisions that enhance sepsis management and reduce the risk of complications and mortality.

Tachyon workflow

Photo by Daniel Olah on Unsplash

Photo by Minimography on Pexels

about HQ Science Ltd.

HQ Science Limited is a UK-based MedTech company specialising in the development of decentralised, point-of-care personalised molecular diagnostics. Our solutions empower healthcare professionals to perform advanced diagnostic testing without the need for specialised laboratories or highly trained bioinformatics personnel. Leveraging the capabilities of our Tachyon platform, we provide rapid and accurate results directly within clinical settings, enhancing efficiency and patient care. Our commitment to accessibility and precision positions us at the forefront of medical diagnostics, supporting health care workers in delivering optimal outcomes.

Team Member

Stanislav Polozov

UK Research and Innovation - endorsed Global Talent in Research and Academia. Stan is founder and director at HQ Science Ltd as well as a collaborator scientist at UK Health Security Agency (UKHSA). At HQ Science, he leads a team of reputable scientists, engineers and business developers across the EU and UK to disrupt the field of personalised diagnostics by providing decentralised molecular diagnostics point-of-care solutions to improve clinical outcomes in patients.

At UKHSA, Stan is responsible for sequencing data analysis for transcriptional, epitranscriptional research, working on various projects related to COVID-19, radiobiology, and point-of-care diagnostics.
Founder & Director of HQ Science

Maria Polozova

Maria Polozova, a Research Officer at HQ Science, is a biomedical scientist with a degree in medicine (Clinical Immunologist, M.D.). She has extensive experience in clinical immunology and molecular biology, gained from her work at the Grigoriev Institute for Medical Radiology and Oncology (GIMRO) and a MELODI-granted fellowship, during which she further honed her skills in molecular biology laboratory techniques.

Maria’s diverse skill set contributes significantly to our research capabilities, as well as the development and implementation of advanced diagnostics at HQ Science.
Research Officer

Dr Veronica Goriacha

Veronica Goriacha, a Bioinformatician and Data Scientist at HQ Science, holds an M.Sc. in Applied Mathematics from Nikolay Zhukovskiy National Aerospace University (NZNAU) and a PhD in applying informatics, machine learning, and neural networks in medical data analysis. Her PhD focused on AI-driven analysis of clinical data to support diagnostics and disease staging in prostate cancer patients, conducted in collaboration with the Grigoriev Institute for Radiology and Oncology.

After completing her PhD, Veronica worked as a software developer before joining HQ Science at the end of 2018 to develop next-generation sequencing technologies for personalised cancer diagnostics. In 2020, she expanded her expertise through a bioinformatics project at the University of Haifa, where she developed R packages for pathway analysis and phylogenetics. Veronica’s skills in AI, bioinformatics, and software development significantly enhance HQ Science’s research and technology capabilities.
Bioinformatician and Data Scientist

Paul Stetsenko

Paul is a results-driven IT professional with extensive experience in database administration, business continuity, cloud security, compliance, and seamless cloud migrations. His technical expertise spans Microsoft SQL Server deployment, administration, and automation, as well as disaster recovery and high availability planning. Paul is skilled in designing and migrating architectures on Amazon Web Services and Azure, with a strong focus on cloud security and Blockchain technology.
IT professional

Roman Belkin

Roman Belkin is an accomplished entrepreneur and business development leader with extensive experience in the technology and healthcare industries. At HQ Science, Roman spearheads strategic growth initiatives, fosters partnerships, and drives the global adoption of cutting-edge molecular diagnostics solutions.

Prior to joining HQ Science, Roman founded Cardiomo, a health-tech company that developed innovative wearable technology for continuous heart activity monitoring using artificial intelligence. Under his leadership, the company secured international investments, won prestigious startup competitions, and successfully launched pilot projects in multiple markets, including the US and Europe.

Roman is passionate about advancing healthcare through technology and is committed to delivering impactful solutions that improve lives worldwide.
Chief Business Development Officer (CBDO), HQ Science

Alex Diatlov

Alex Diatlov is an experienced entrepreneur and operational leader with over 11 years of experience in entrepreneurship, operations, and product management.

Alex’s career includes leading VC-backed hardware startups such as Ecoisme, where he secured partnerships with industry giants like T-Mobile and Virgin Media. At Series C startup Very Good Security, Alex played a pivotal role in optimising operational processes and scaling organizational efficiency.

At HQ Science, Alex focuses on managing operational processes and leading strategic initiatives. His goal is to ensure that clients have seamless access to HQ Science’s innovative molecular diagnostics solutions, supporting the company’s mission to revolutionise molecular diagnostics with faster, more affordable, and decentralised point-of-care technologies.
Chief Operating Officer (COO), HQ Science

Chris Shpilka

Chris Shpilka - serial entrepreneur, 11 years of experience leading tech teams and business development.
serial entrepreneur
Previous
Next

Adviser

Steffen brings a robust engineering background across various industries and markets. He founded his own startup and has focused primarily on back-end development, emphasizing scalability. Notably, he was part of the team that built one of Europe's largest social networks. Steffen has always been driven by the desire to solve technical challenges, leading diverse technical teams in industries such as health, science, and gaming. In addition to his software expertise, he has experience in developing hardware products for the health industry. Steffen is also well-versed in AWS and GCP cloud solutions, underscoring his versatility and comprehensive skill set.

Steffen Irrgang

Title
Katharina is a seasoned software engineer with a rich background in developing and managing mobile banking backend microservices on AWS Cloud. Her expertise extends to monolithic backend systems for blogging software, with significant contributions to open source projects and SDKs. With over a decade of experience in Node.js and more than six years dedicated to open source development, Katharina has consistently demonstrated her technical prowess. She has played crucial roles in implementing security scans and quickly rose to leadership positions in every company she joined, showcasing her capability to lead and innovate in dynamic environments.

Katerina Irrgang

Title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris accumsan urna eu pharetra elementum. Suspendisse potenti.

Vestibulum ut quam luctus, pharetra dui sed, rutrum felis. Vestibulum tellus ipsum, rhoncus sed suscipit a, eleifend in.

Dr. Christoph Badie

Title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris accumsan urna eu pharetra elementum. Suspendisse potenti.

Vestibulum ut quam luctus, pharetra dui sed, rutrum felis. Vestibulum tellus ipsum, rhoncus sed suscipit a, eleifend in.

Dr. Lourdes

Title
Previous
Next

Collabrator

UKHSA

Title
Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

Lille

Title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris accumsan urna eu pharetra elementum. Suspendisse potenti.

Vestibulum ut quam luctus, pharetra dui sed, rutrum felis. Vestibulum tellus ipsum, rhoncus sed suscipit a, eleifend in.

Norway

Title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris accumsan urna eu pharetra elementum. Suspendisse potenti.

Vestibulum ut quam luctus, pharetra dui sed, rutrum felis. Vestibulum tellus ipsum, rhoncus sed suscipit a, eleifend in.

GIMRO

Title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris accumsan urna eu pharetra elementum. Suspendisse potenti.

Vestibulum ut quam luctus, pharetra dui sed, rutrum felis. Vestibulum tellus ipsum, rhoncus sed suscipit a, eleifend in.

Colombia

Title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Mauris accumsan urna eu pharetra elementum. Suspendisse potenti.

Vestibulum ut quam luctus, pharetra dui sed, rutrum felis. Vestibulum tellus ipsum, rhoncus sed suscipit a, eleifend in.
Previous
Next

Team Member

Stanislav Polozov

Stanislav Polozov, CEO of HQ Science, is a seasoned oncologist with a rich background in medical education and clinical oncology. Coming from a lineage of six generations of doctors, Stan’s expertise in radiation therapy and cancer complexities drives his mission to integrate advanced technologies into medical practice. Leading the development of the Tachyon Device at HQ Science, he has created a tool that not only revolutionizes cancer care but also adapts to various medical fields, from genetics to infectious diseases. The device uses long-read sequencing and AI to deliver personalized diagnostics by analyzing each patient’s genetic profile, enabling precise and effective treatments. Known for his global outreach, Stan has built partnerships with top research institutions and healthcare organizations, enhancing the understanding and application of molecular diagnostics. Under his guidance, HQ Science aims to make advanced diagnostic and therapeutic technologies accessible worldwide, catering to diverse medical needs.

Dr Veronica Goriacha

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

Maria Polozov

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

Paul

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

Adviser

Steffen Irrgang

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

Katerina Irrgang

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

Dr. Christoph Badie

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

Dr. Lourdes

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

Collabrators

UKHSA

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

Lille

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

Norway

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

GIMRO

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

Colombia

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.